Engflag

Promazine

Quick links to important sections

Promazine

Promazine_DE

Method of action: Antiemetic, Antipsychotic, Hypotensive, Psycholeptics

Treatment option: Autism, Meniere Disease, Hypomania, Dermatitis, Childhood Schizophrenia, Hiccups, Mania, Anxiety&Panic Attacks, Psychosis, Burping

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Promazine

What is Promazine?

Promazine is a pharmaceutical compound belonging to the class of medications known as phenothiazines. It is primarily categorized as a typical antipsychotic, also referred to as a first-generation antipsychotic. Developed in the mid-20th century, it was designed to help manage various manifestations of psychomotor agitation and certain psychiatric conditions.

Chemical Class and Mechanism

As a phenothiazine derivative, promazine functions by interacting with neurotransmitter receptors in the brain. Its primary action involves the blockade of dopamine receptors, particularly the D2 subtype, in different pathways of the central nervous system. By modulating dopamine activity, the medication helps to stabilize mood and reduce excessive physical or mental overactivity.

In addition to its effects on dopamine, promazine also possesses properties that affect other neurotransmitter systems, including:

  • Antihistaminic activity: Contributing to its sedative effects.
  • Anticholinergic activity: Affecting the parasympathetic nervous system.
  • Alpha-adrenergic antagonism: Influencing blood pressure and vascular response.

General Uses

Promazine is used in clinical settings to address symptoms rather than to cure underlying conditions. Its profile is characterized by a moderate level of potency and a significant sedative effect, making it useful in specific scenarios where calming a patient is a primary therapeutic goal.

Common applications include:

  • Agitation and Restlessness: Management of short-term agitation in patients, particularly in those with chronic mental health issues.
  • Nausea and Vomiting: Like several other phenothiazines, it has antiemetic properties, though it is less commonly used for this purpose today.
  • Adjunctive Sedation: Used in some instances to assist with restlessness associated with various medical or psychological states.

Historical Context

Promazine was part of the first wave of antipsychotic medications that transformed psychiatric care. While it remains available in several regions, its use has largely been superseded in many clinical practices by newer, atypical antipsychotics that offer different side effect profiles and more targeted receptor activity.

What side effects are possible with Promazine?

Adverse Reactions and Safety Information

Promazine, a phenothiazine-type medicine, is associated with a range of side effects, some of which are serious and clinically significant.

Key Adverse Reactions

Adverse effects commonly involve the Nervous System (e.g., drowsiness, sedation, confusion, headache, epileptic fits) and Cardiovascular System (e.g., hypotension).

  • Extrapyramidal Symptoms (EPS): Uncontrolled movements are possible, including dystonia, akathisia, and tremor. Tardive Dyskinesia, a potentially persistent form of EPS, is a documented risk, especially with prolonged use.
  • Serious Cardiovascular Risks: Rare but severe adverse reactions include QT-interval prolongation, Torsades de Pointes, ventricular arrhythmias (such as ventricular fibrillation), and cardiac arrest. Cases of sudden unexplained death and venous thromboembolism (VTE) have been reported, representing a known class effect for antipsychotics.
  • Other Serious Events: The rare but potentially fatal Neuroleptic Malignant Syndrome (NMS), characterized by fever, muscular rigidity, and autonomic dysfunction, can occur. Blood disorders such as agranulocytosis and leucopenia have been reported.

Safety Restrictions and Population Considerations

Promazine is formally contraindicated in conditions including coma, severe central nervous system depression, bone marrow depression, and phaeochromocytoma.

The Elderly are particularly susceptible to certain adverse effects, including sedation, hypotension, and disruption of temperature regulation (risk of hypothermia/hyperthermia), and they face a documented increased risk of cerebrovascular events and mortality when the drug is used for dementia-related psychosis. Dosage-related side effects include hypotension and thermal dysregulation.

Use requires particular caution in patients with a history of liver or cardiac disease, epilepsy, Parkinsonism, and narrow-angle glaucoma. Abrupt cessation of the drug may lead to withdrawal symptoms and should generally be avoided unless a serious side effect necessitates immediate discontinuation.

Overdose and Emergency Response

The official regulatory documentation classifies Promazine as highly toxic in overdose, with ingestion of a toxic dose being likely to cause serious toxicity or death. This extreme severity triggers the regulatory requirement to seek urgent medical attention immediately. The official overdose profile documents severe effects across multiple physiological systems, primarily affecting the Central Nervous System (CNS) and the Cardiovascular system.

Overdose Manifestations and Urgent Action

System Affected Officially Documented Manifestation
Central Nervous System grand mal seizures, coma
Cardiovascular System hypotension, tachycardia / arrhythmia
Physiological Findings QRS prolongation, QTc prolongation

The documentation of life-threatening events dictates the immediate need for emergency response. Clinical manifestations explicitly listed include major neurological complications such as grand mal seizures and a profound loss of consciousness, described as coma. Furthermore, the overdose scenario involves critical cardiovascular changes, including hypotension and arrhythmia, along with specific documented ECG abnormalities such as QRS prolongation and QTc prolongation. The combination of these severe neurological and cardiac findings, as classified in regulatory documents, constitutes the official definition of a life-threatening overdose state. Urgent medical attention is mandatory for any exposure approaching this level of toxicity.

Therapeutic Uses of Promazine

What Promazine Treats: Main Uses and Benefits

Promazine is commonly used in situations involving certain distressing symptoms, primarily focusing on acute states of agitation and severe sickness. It is applied across domains where additional symptomatic support is needed, particularly in conditions characterized by periods of heightened symptoms.

The medication is relevant for easing acute behavioral distress, managing symptoms that interfere with daily functioning, such as severe restlessness and psychomotor agitation, and is commonly used to help with severe nausea and vomiting. This supportive relief may help maintain a sense of stability when symptoms are more noticeable.

“Promazine is considered relevant for easing symptoms that have become temporarily overwhelming, offering support when acute manifestations interfere with function.”

The overall benefit contributes to easing the overall symptom load during symptomatic periods, supporting the patient during difficult episodes.

Quick Fact: Support for Acute Distress

Quick Fact: Support for Severe Agitation and Nausea. Promazine supports the patient during difficult episodes by providing short-term symptomatic assistance when symptoms of restlessness or sickness become momentarily overwhelming.

Regulatory References

  1. National Health Service (NHS) guidance

Eligibility and Restrictions for Use

Eligibility Profile: Who Can and Cannot Use Promazine?

The official eligibility criteria for Promazine are strictly defined by regulatory agencies and establish populations who must not use the medicine (contraindications) and those who require restricted use.

Absolute Contraindications

Promazine is contraindicated and must not be used in individuals with:

  • A known hypersensitivity to promazine or any other phenothiazines.
  • A comatose state or severe central nervous system (CNS) depression.
  • Bone marrow depression or phaeochromocytoma.
  • Pediatric patients under two years of age (due to the risk of fatal respiratory depression).

Restricted or Conditional Use

Use of Promazine requires special caution and close supervision for:

  • Elderly patients, who generally require a lower starting dose.
  • Patients with impaired liver function (jaundice) or cardiac disease.
  • Individuals with a history of seizure disorders.

Age and Life-Stage Eligibility

Population Group Eligibility Status
Children <2 years Contraindicated
Children ge 2 years Restricted Use (Caution)
Pregnant Women Generally Contraindicated
Breastfeeding Women Generally Contraindicated

All use must be determined by a healthcare professional based on individual patient assessment.

What should I know about interactions with other medicines?

Promazine Interactions with other medicines and products

Official regulatory information outlines specific drug-drug and drug-product interactions for Promazine, primarily focusing on additive effects and changes in plasma concentration.

Formal Interaction Classifications

Interaction Type Interacting Agents / Classes Constraint / Effect in Label
Contraindicated Risk Drugs that prolong the QT interval (e.g., Amiodarone) Co-administration is not recommended due to increased risk of serious ventricular arrhythmias.
Pharmacodynamic Central Nervous System (CNS) Depressants, including Alcohol, Opioids, Sedatives, General Anaesthetics Potentiation or accentuation of sedative and hypotensive effects.
Pharmacokinetic Ritonavir, Cimetidine May lead to an increase in plasma concentration of the antipsychotic drug.
Absorption Antacids and Kaolin May reduce the absorption of Promazine, potentially lowering its systemic exposure.

Procedural and Population-Specific Notes

  • Diagnostic Constraints: Due to its antihistaminic properties, Promazine should be discontinued for at least 72 hours before certain allergy skin tests to prevent false-negative results, as specified in regulatory documents.
  • Antagonism: The drug may decrease the therapeutic effects of Dopamine and Apomorphine due to direct pharmacodynamic antagonism.
  • Pediatric and Elderly Populations: The regulatory label notes that children may be particularly susceptible to additive respiratory depressant effects when Promazine is combined with other respiratory depressants. Elderly patients may be more prone to effects such as confusion and severe drowsiness when co-administered with other CNS depressants.

This interaction profile establishes restrictions, noting the formal risk classification for co-use with QT-prolonging agents. The documentation further identifies specific medicinal products, such as Ritonavir and Cimetidine, that are implicated in modulating the drug's systemic exposure. The profile also includes necessary procedural constraints, such as the required timing separation before diagnostic testing.

Mechanism of Action

Promazine functions as a non-selective antagonist (blocker) across multiple monoamine receptor systems. Its primary action involves blocking dopamine D2 receptors in the central nervous system (CNS), particularly within the mesolimbic pathway and the Chemoreceptor Trigger Zone (CTZ). By binding to these sites, Promazine prevents dopamine from activating the receptors, thereby decreasing the overall level of dopaminergic signaling. This action in the CTZ directly inhibits the signaling pathway that mediates the emetic reflex. Promazine also strongly antagonizes histamine H1 receptors in the CNS, suppressing histamine's role as a wakefulness-promoting neurotransmitter, which results in a sedative consequence and CNS depression. Additionally, antagonism of alpha1-adrenergic receptors on blood vessels disrupts the signaling that causes vasoconstriction. This interference reduces peripheral vascular resistance, leading to a change in blood pressure and orthostatic hypotension.

Dosage and Administration Information

How Promazine Is Used: Official Administration Guidelines

Promazine administration follows established guidelines focusing on approved routes, specific dose ranges, and defined duration limits. The medicine is available as oral forms (syrup and tablets) and an injectable solution for intramuscular (IM) use, which is typically reserved for the initial, acute control of symptoms.

Official Usage Scope

Usage Aspect Administration Guidelines
Route of Administration Oral (PO) and Intramuscular (IM) injection.
Adult Dosing Regimen Initial oral dose is often 100 mg, with a typical maintenance range of 100 mg to 200 mg.
Frequency Pattern Doses are commonly administered at six-to-eight-hour intervals, or may be given as a single bedtime dose to manage acute symptoms.
Duration Framework Use is designated for short-term management only, and the medication must be used for the shortest period possible.

Procedural and Population Requirements

The usage protocol emphasizes a careful and supervised approach. Commencement of the regimen and any subsequent dosage increases must occur under close clinical supervision. The protocol requires starting with a low initial dose and increasing the amount in frequent, regular intervals until the required level is reached.

Standard instructions specify distinct protocols for certain populations. For older adults (the elderly), the starting dose is significantly lower, typically 25 mg, with lower limits on the maximum daily dose. Conversely, the use of Promazine is not recommended in the pediatric population. This structured approach ensures administration remains strictly within established bounds.

Recent Clinical Evidence

Promazine: Recent Clinical Evidence

This summary provides an overview of research and clinical trials related to promazine. This information details what studies have investigated regarding the drug, not what its effects are guaranteed to be. Individuals may wish to discuss this information with a healthcare provider for personalized context.

Scope of Clinical Investigation

Clinical research primarily focuses on promazine's role within the class of phenothiazine antipsychotics, a group of compounds that act on the central nervous system. Modern studies generally examine its application in specific, short-term management settings.

  • Acute Agitation: Research has investigated the use of promazine for the rapid control of acute psychomotor agitation and behavioral disturbance. Studies have evaluated whether promazine is associated with changes in agitation severity within the first few hours of administration.

  • Efficacy Comparison: Comparative trials have been conducted to evaluate the differences between promazine and newer-generation antipsychotics in managing psychosis-related symptoms. The focus of these studies is often on balancing potential outcomes with the incidence of adverse effects.

️ Safety and Long-Term Use Research

Safety investigation remains a priority due to the potential for adverse effects common to this drug class.

  • Adverse Events: Research frequently addresses the prevalence of extrapyramidal symptoms (EPS) and sedation following promazine administration. Studies examine the relationship between dosage adjustments and the occurrence of these neurological effects.

  • Drug Interactions: Studies have identified potential interactions when promazine is co-administered with other central nervous system depressants or certain medications affecting liver enzymes. This finding suggests a need for further research to understand full clinical risk profiles.

Key Studies & References A review of extrapyramidal symptoms associated with typical antipsychotics

How should Promazine be stored and disposed of?

How to Store and Dispose of Promazine

Promazine Hydrochloride must be stored at Controlled Room Temperature, defined as 20 C to 25 C (68 F to 77 F). The official label mandates that the medication be stored in its original container, kept tightly closed, and specifically protected from light and excess moisture.

Required Handling and Disposal

The product must be stored out of the sight and reach of children. Regarding disposal, unused or expired Promazine must be discarded according to local regulations. Regulatory documents explicitly state that the medicine should not be flushed down the toilet or poured down any drain to prevent environmental contamination. When local rules permit household disposal, the product should be mixed with an undesirable substance and sealed in a bag before being placed in the trash.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

flagPhilippines

Equivalent of Promazine found in:

A-Z Index: